# Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

> **NCT04324125** · — · RECRUITING · sponsor: **Hunan Province Tumor Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04324125
- **Lead sponsor:** Hunan Province Tumor Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-24
- **Primary completion:** 2024-12-24
- **Final completion:** 2025-03-24
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04324125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04324125, "Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04324125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*